Hepion Pharmaceuticals, Inc. (CTRVP) Free cash flow 2016–2024
Hepion Pharmaceuticals, Inc. (CTRVP) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$18.2MFY2024 · since FY2016: -$19.2M → -$18.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$18.2M | +55.4% |
| FY2023 | -$40.9M | -16.6% |
| FY2022 | -$35.1M | -12.1% |
| FY2021 | -$31.3M | -93.1% |
| FY2020 | -$16.2M | — |
| FY2016 | -$19.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice